|
| Mean Recommendation (this week): | 2.1 | | Mean Recommendation (last week): | 2.1 | | Change: | 0.0 |
|
| Mean Target: | 41.00 | | Median Target: | 44.00 | | High Target: | 75.00 | | Low Target: | 14.00 | | No. of Brokers: | 7 |
|
|
|
|
|
| UPGRADES & DOWNGRADES HISTORY |
| Date | Research Firm | Action | From | To | | 5-Nov-09 | Roth Capital | Upgrade | Hold | Buy | | 29-Oct-09 | JP Morgan | Initiated | | Overweight | | 5-Mar-09 | Hapoalim | Initiated | | Outperform | | 26-Feb-09 | Roth Capital | Downgrade | Buy | Hold | | 12-Aug-08 | RBC Capital Mkts | Downgrade | Outperform | Sector Perform | | 8-Jul-08 | Rodman & Renshaw | Upgrade | Mkt Perform | Mkt Outperform | | 29-Jan-08 | Stanford Research | Upgrade | Hold | Buy | | 17-Jan-08 | Roth Capital | Initiated | | Buy | | 7-Nov-07 | Brean Murray | Initiated | | Sell | | 31-Oct-07 | Pacific Growth Equities | Initiated | | Buy |
|
Data provided by Briefing.com - Take a Free Trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights. |
|
| Current Month | Last Month | Two Months Ago | Three Months Ago | | Strong Buy | 4 | 3 | 3 | 3 | | Buy | 3 | 3 | 1 | 1 | | Hold | 2 | 2 | 3 | 3 | | Underperform | 0 | 0 | 0 | 0 | | Sell | 1 | 1 | 1 | 1 |
|
|
|
0.49% Nasdaq 
Analyst Opinion
